Side effect | All cases (n = 85) (Median (25th–75th percentile) | Just imepitoin monotherapy cases (n = 56) (Median (25th–75th percentile) | ||
---|---|---|---|---|
Initial 2Â weeks | After 2Â weeks | Initial 2Â weeks | After 2Â weeks | |
Eating more / would like to eat more | 3 (0–4) | 2 (0–4) | 2 (0–4) | 1 (0–4) |
Gaining weight | 0 (0–3) | 0 (0–2) | 0 (0–3) | 0 (0–2) |
Drinking more | 2 (0–3) | 1 (0–3) | 1 (0–3) | 1 (0–2.75) |
Urinating more | 1 (0–3) | 0 (0–2.5) | 0 (0–3) | 0 (0–2) |
Sleeping more than before | 1 (0–3) | 0 (0–2) | 1 (0–3) | 0 (0–2.75) |
Wobbly / not coordinated when walking | 0 (0–3) | 0 (0–1) | 0 (0–1.75) | 0 (0–0) |
Restlessness / pacing | 0 (0–3) | 0 (0–2) | 0 (0–2) | 0 (0–1) |
Itchiness or skin rash | 0 (0–0) | 0 (0–0) | 0 (0–0) | 0 (0–0) |
Vomiting | 0 (0–0) | 0 (0–0) | 0 (0–0) | 0 (0–0) |
Diarrhoea | 0 (0–0) | 0 (0–0) | 0 (0–0) | 0 (0–0) |
Coughing | 0 (0–0) | 0 (0–0) | 0 (0–0) | 0 (0–0) |
OVERALL SCORE (out of 55) | 13 (4–19.5) | 9 (1.5–15.5) | 10 (2–16) | 7 (1–13.75) |